新闻

Shanghai, June 26, 2025 —Dr. Reddy’s Laboratories’ Active Pharmaceutical Ingredients (API) business made a dynamic appearance at CPHI China 2025, held at the Shanghai New International Expo Center from June 24–26. Held at the Shanghai New International Expo Center, the event gave us the opportunity to connect with formulation partners, regulatory experts, and innovators from around the world. We proudly presented our portfolio of 250+ APIs, spanning oncology, cardiology, pain management, and more each backed by rigorous science and global regulatory compliance. Our team, led by Deepak Sapra and Nirav Shah, engaged in meaningful conversations around early market entry strategies, complex API development, and sustainable manufacturing practices. We were especially excited to share our progress on ESG goals and our recognition in global sustainability indices. /p>